{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:07:59Z","timestamp":1778825279069,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["FK 138929"],"award-info":[{"award-number":["FK 138929"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jcf.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:48:13Z","timestamp":1747669693000},"page":"733-740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pancreatic islet autoantibodies and their association with glycemic status in cystic fibrosis patients: A comprehensive meta-analysis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7067-1647","authenticated-orcid":false,"given":"Regina","family":"Moln\u00e1r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka Rebeka","family":"B\u00f3dy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bor\u00f3ka","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"K\u00f3i","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-3463","authenticated-orcid":false,"given":"Dorottya","family":"Gerg\u0151","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikl\u00f3s","family":"Garami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5355-4224","authenticated-orcid":false,"given":"Katalin Eszter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Hegyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5848-2506","authenticated-orcid":false,"given":"Klementina","family":"Ocskay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-4780","authenticated-orcid":false,"given":"Andrea","family":"P\u00e1rniczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.04.011_bib0001","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2025.04.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2024.02.010","article-title":"Early onset of abnormal glucose tolerance in patients with cystic fibrosis: a systematic review and meta-analysis","author":"K\u00e9ri","year":"2024","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.04.011_bib0003","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD clinical practice consensus guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.jcf.2025.04.011_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.702823","article-title":"The potential causes of cystic fibrosis-related diabetes","volume":"12","author":"Coderre","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcf.2025.04.011_bib0005","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jcf.2015.02.009","article-title":"Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients","volume":"14","author":"Wooldridge","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.04.011_bib0006","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.2337\/dc11-2327","article-title":"No relation between cystic fibrosis-related diabetes and type 1 diabetes autoimmunity","volume":"35","author":"Gottlieb","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.04.011_bib0007","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/dc16-0020","article-title":"Does \u03b2-cell autoimmunity play a role in cystic fibrosis-related diabetes? analysis based on the German\/Austrian diabetes patienten verlaufsdokumentation registry","volume":"39","author":"Konrad","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.04.011_bib0008","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2025.04.011_bib0009","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpeds.2007.09.025","article-title":"Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis","volume":"152","author":"Bismuth","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2025.04.011_bib0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1651-2227.1993.tb12628.x","article-title":"Diabetes mellitus in cystic fibrosis: genetic and immunological markers","volume":"82","author":"Lanng","year":"1993","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2025.04.011_bib0011","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/clinchem\/45.12.2269","article-title":"Glutamic acid decarboxylase antibodies in screening for autoimmune diabetes: influence of comorbidity, age, and sex on specificity and threshold values","volume":"45","author":"Batstra","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jcf.2025.04.011_bib0012","series-title":"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus","year":"1999"},{"key":"10.1016\/j.jcf.2025.04.011_bib0013","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jcf.2013.03.001","article-title":"ZnT8 antibodies in patients with cystic fibrosis: an expression of secondary beta-cell damage?","volume":"12","author":"Bizzarri","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.04.011_bib0014","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"The Expert Committee on the Diagnosis and Classification of Diabetes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.04.011_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2007-1003737","article-title":"Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance","volume":"23","author":"De Luca","year":"1991","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jcf.2025.04.011_bib0016","series-title":"Diabetes Mellitus: Report of a WHO Study Group [Meeting Held in Geneva From 11 to 16 February 1985]","year":"1985"},{"key":"10.1016\/j.jcf.2025.04.011_bib0017","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3476(88)80324-X","article-title":"Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis","volume":"112","author":"Geffner","year":"1988","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2025.04.011_bib0018","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","author":"National Diabetes Data Group","year":"1979","journal-title":"Diabetes."},{"key":"10.1016\/j.jcf.2025.04.011_bib0019","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcf.2011.11.001","article-title":"Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus","volume":"11","author":"Hillman","year":"2011","journal-title":"J Cyst Fibros: Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.jcf.2025.04.011_bib0020","first-page":"405","article-title":"Mosnier-Pudar H. Effect of repaglinide therapy in adult patients with cystic fibrosis related diabetes","volume":"46","author":"Hubert","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.04.011_bib0021","first-page":"S1","article-title":"Contribution of autoimmunity to etiopathogenesis of CFRD - preliminary results","volume":"1","author":"Kolouskova","year":"2002","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.04.011_bib0022","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1183\/09031936.00006009","article-title":"Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis","volume":"34","author":"Lachenal","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2025.04.011_bib0023","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-5491.1991.tb02118.x","article-title":"Islet cell cytoplasmic antibodies (ICA) in diabetes and disorders of glucose tolerance","volume":"8","author":"Marner","year":"1991","journal-title":"Diabet Med"},{"key":"10.1016\/j.jcf.2025.04.011_bib0024","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1515\/JPEM.2005.18.8.755","article-title":"Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis","volume":"18","author":"Minicucci","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.04.011_bib0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/JPEM.2000.13.3.319","article-title":"Islet autoantibodies and insulin dependent diabetes mellitus in cystic fibrosis","volume":"13","author":"Nousia-Arvanitakis","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.04.011_bib0026","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/dc06-1915","article-title":"Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation","volume":"30","author":"Preumont","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.04.011_bib0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(99)00058-3","article-title":"Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report","volume":"45","author":"Moran","year":"1999","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/j.jcf.2025.04.011_bib0028","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/adc.2010.208652","article-title":"Increased detection of cystic-fibrosis-related diabetes in Australia","volume":"96","author":"Rana","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2025.04.011_bib0029","first-page":"17","article-title":"Factors for glucose intolerance in cystic fibrosis","volume":"49","author":"Robert","year":"1992","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/j.jcf.2025.04.011_bib0030","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/adc.63.10.1234","article-title":"HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis","volume":"63","author":"Stutchfield","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jcf.2025.04.011_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(87)92355-5","article-title":"Autoimmunity, diabetes, and cystic fibrosis","volume":"2","author":"Wilkin","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2025.04.011_bib0032","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.04.011_bib0033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/jaut.1999.0281","article-title":"Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives","volume":"12","author":"Maclaren","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jcf.2025.04.011_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.815703","article-title":"The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: a global scoping review","volume":"13","author":"Ross","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcf.2025.04.011_bib0035","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2025.04.011_bib0036","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","article-title":"Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study","volume":"39","author":"Vehik","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2025.04.011_bib0037","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1210\/jc.2002-020018","article-title":"Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population","volume":"87","author":"Kimpim\u00e4ki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.04.011_bib0038","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1210\/jc.2003-031887","article-title":"Prediction of autoantibody positivity and progression to type 1 diabetes: diabetes autoimmunity study in the young (DAISY)","volume":"89","author":"Barker","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2025.04.011_bib0039","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2025.04.011_bib0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000525824","article-title":"Screening of islet autoantibodies for children in the general population: a position statement endorsed by the European Society for Paediatric Endocrinology","volume":"95","author":"Chiarelli","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.jcf.2025.04.011_bib0041","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41436-020-01073-x","article-title":"Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth","volume":"23","author":"Lin","year":"2021","journal-title":"Genet Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325014663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325014663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:15:36Z","timestamp":1778822136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325014663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1569199325014663"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.04.011","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic islet autoantibodies and their association with glycemic status in cystic fibrosis patients: A comprehensive meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}